euro adhoc: Curanum AG
Financial Figures/Balance Sheet
CURANUM AG: Audit of 2005 annual financial statements concluded, figures confirmed

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc.   The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@


The audit of the 2005 annual financial statements of CURANUM AG, Munich, was today concluded with the issue of the audit certificate. The key figures already announced for sales (EUR 188.5 million), EBITDA (EUR 25.8 million), EBIT (EUR 19.6 million) and EBT (EUR 12.2 million) remained unchanged. While earnings after taxes, at EUR 7.3 million (PY: EUR 4.9 million) were EUR 0.2 million lower than the published figure, cash flow, at EUR 12.7 million, exceeded the previously announced figure by EUR 0.4 million (PY: EUR 21.4 million). EPS were thus EUR 0.25 (PY: EUR 0.17), an increase of 47% compared to the previous year. As already announced, the auditors issued the financial statements with a qualified audit opinion.

The Management Board is assuming that, in the current situation, the Company’s shareholders will benefit more from rapid and profitable growth than from the payment of a higher dividend. Since the care market is currently offering many favourable opportunities for acquisitions, the Management and Supervisory Boards will propose to the Annual General Meeting the distribution of EUR 0.10 per share, in total EUR 3.0 million, from distributable reserves of EUR 12.6 million (PY: EUR 10.4 million)

Munich, 28 April 2006

The Management Board

--------------------------End of Ad hoc report--------------------------------

Explanation of qualification of audit certificate:

The auditors issued a qualified audit certificate on several grounds, which the Management Board of CURANUM AG either deem to be incorrect or on which the Management Board hold a different opinion. The Company will supply a table providing a detailed explanation of the different standpoints and their consequences upon request. CEO Hans-Milo Halhuber will also explain the relevant matters as a part of a conference call and following Q&A session on Tuesday 2 May 2006, at 10.00 hrs.

@@start.t2@@end of announcement                                                 euro adhoc 28.04.2006 17:35:51

ots Originaltext: Curanum AG
Im Internet recherchierbar:

Further inquiry note:
Bernd Rothe
Tel.: +49 (0)89 242065-60

Branche: Healthcare Providers
ISIN:      DE0005240709
WKN:        524070
Index:    CDAX, Classic All Share, Prime All Share, SDAX
Börsen:  Frankfurter Wertpapierbörse / regulated dealing/prime
              Bayerische Börse / regulated dealing
              Börse Berlin-Bremen / free trade
              Hamburger Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade

Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: